$140.85
al cierre: Nov 12 EDT
$141.93
1.080.77%
Pre-comercialización: 5:59 AM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Phillips 66 tiene un precio objetivo de consenso de $146.05 basado en las calificaciones de 23 analistas. El máximo es $180, emitido por B of A Securities el marzo 15, 2024. El mínimo es $122, emitido por Morgan Stanley el abril 24, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por UBS, Freedom Capital Markets y TD Cowen el noviembre 3, 2025, noviembre 3, 2025 y octubre 30, 2025, respectivamente. Con un precio objetivo promedio de $147.67 entre UBS, Freedom Capital Markets y TD Cowen, hay una 4.04% upside implícita para Phillips 66 según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
UBS
Freedom Capital Markets
TD Cowen
Wells Fargo
Piper Sandler
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Phillips 66
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/03/2025 | 12.73% | UBS | $150 → $160 | Maintains | Buy | |||
11/03/2025 | -2.77% | Freedom Capital Markets | $127 → $138 | Downgrade | Buy → Hold | |||
10/30/2025 | 2.16% | TD Cowen | $140 → $145 | Maintains | Buy | |||
10/30/2025 | 14.14% | Wells Fargo | $154 → $162 | Maintains | Overweight | |||
10/30/2025 | 12.03% | Piper Sandler | $155 → $159 | Maintains | Neutral | |||
10/17/2025 | 5.69% | Raymond James | $145 → $150 | Reiterates | Outperform → Outperform | |||
10/17/2025 | 8.5% | Wells Fargo | → $154 | Initiates | → Overweight | |||
10/10/2025 | -3.47% | Jefferies | $133 → $137 | Maintains | Hold | |||
10/07/2025 | -7% | Barclays | $127 → $132 | Maintains | Equal-Weight | |||
10/03/2025 | -1.36% | Morgan Stanley | $128 → $140 | Maintains | Equal-Weight | |||
09/29/2025 | 9.21% | Piper Sandler | $154 → $155 | Maintains | Neutral | |||
09/22/2025 | 5.69% | UBS | $143 → $150 | Maintains | Buy | |||
09/19/2025 | 19.78% | Evercore ISI Group | $130 → $170 | Maintains | Outperform | |||
09/15/2025 | 0.05% | Mizuho | $140 → $142 | Maintains | Neutral | |||
09/11/2025 | 8.5% | Piper Sandler | $144 → $154 | Maintains | Neutral | |||
09/09/2025 | 2.16% | Raymond James | $142 → $145 | Maintains | Outperform | |||
09/03/2025 | 3.57% | B of A Securities | $144 → $147 | Downgrade | Buy → Neutral | |||
08/04/2025 | 2.16% | Piper Sandler | $144 → $145 | Maintains | Neutral | |||
07/28/2025 | 0.75% | UBS | $141 → $143 | Maintains | Buy | |||
07/28/2025 | 1.46% | Piper Sandler | $147 → $144 | Maintains | Neutral | |||
07/22/2025 | 3.57% | Piper Sandler | $148 → $147 | Maintains | Neutral | |||
07/16/2025 | -9.81% | Morgan Stanley | $122 → $128 | Maintains | Equal-Weight | |||
07/16/2025 | -8.41% | Citigroup | $126 → $130 | Downgrade | Buy → Neutral | |||
07/15/2025 | 0.05% | Raymond James | $135 → $142 | Maintains | Outperform | |||
07/11/2025 | -6.29% | Scotiabank | → $133 | Downgrade | Sector Outperform → Sector Perform | |||
07/10/2025 | 4.28% | Piper Sandler | $131 → $148 | Maintains | Neutral | |||
07/09/2025 | -10.52% | Barclays | $115 → $127 | Maintains | Equal-Weight | |||
06/18/2025 | -8.41% | Evercore ISI Group | → $130 | Initiates | → Outperform | |||
06/11/2025 | 3.57% | Wells Fargo | $149 → $147 | Maintains | Overweight | |||
05/13/2025 | -2.77% | Mizuho | $132 → $138 | Maintains | Neutral | |||
05/12/2025 | -18.97% | Barclays | $106 → $115 | Maintains | Equal-Weight | |||
04/29/2025 | -7.7% | JP Morgan | $138 → $131 | Maintains | Overweight | |||
04/28/2025 | -1.36% | UBS | $144 → $140 | Maintains | Buy | |||
04/28/2025 | 4.98% | Wells Fargo | $162 → $149 | Maintains | Overweight | |||
04/24/2025 | -14.04% | Morgan Stanley | $140 → $122 | Maintains | Equal-Weight | |||
04/11/2025 | -6.29% | Scotiabank | $136 → $133 | Maintains | Sector Outperform | |||
04/10/2025 | -25.32% | Barclays | $135 → $106 | Maintains | Equal-Weight | |||
04/09/2025 | -1.36% | Raymond James | $150 → $140 | Maintains | Outperform | |||
04/09/2025 | -7% | Mizuho | $140 → $132 | Maintains | Neutral | |||
03/27/2025 | -7% | Goldman Sachs | $132 → $132 | Downgrade | Buy → Neutral | |||
03/14/2025 | -4.88% | Barclays | $115 → $135 | Maintains | Equal-Weight | |||
02/03/2025 | 14.14% | Wells Fargo | $161 → $162 | Maintains | Overweight | |||
01/13/2025 | -18.97% | Barclays | $124 → $115 | Maintains | Equal-Weight | |||
01/03/2025 | — | Wolfe Research | — | Upgrade | Peer Perform → Outperform | |||
12/16/2024 | 3.57% | Mizuho | $150 → $147 | Maintains | Neutral | |||
12/10/2024 | -1.36% | JP Morgan | $141 → $140 | Maintains | Overweight | |||
12/09/2024 | 13.44% | Wells Fargo | $167 → $161 | Maintains | Overweight | |||
11/11/2024 | -12.63% | Barclays | $133 → $124 | Maintains | Equal-Weight | |||
11/04/2024 | -2.77% | UBS | $150 → $138 | Maintains | Buy | |||
10/17/2024 | 9.91% | B of A Securities | → $156 | Reinstates | → Buy | |||
10/10/2024 | -4.18% | Scotiabank | $145 → $136 | Maintains | Sector Outperform | |||
10/09/2024 | 17.66% | Wells Fargo | $182 → $167 | Maintains | Overweight | |||
10/08/2024 | -6.29% | Barclays | $138 → $133 | Maintains | Equal-Weight | |||
10/08/2024 | 1.46% | Piper Sandler | $136 → $144 | Maintains | Overweight | |||
10/02/2024 | -0.66% | JP Morgan | $160 → $141 | Maintains | Overweight | |||
09/20/2024 | -4.18% | Piper Sandler | $151 → $136 | Maintains | Overweight | |||
09/16/2024 | 1.46% | Morgan Stanley | $150 → $144 | Maintains | Equal-Weight | |||
09/16/2024 | 5.69% | Mizuho | $154 → $150 | Maintains | Neutral | |||
09/11/2024 | 5.69% | TD Cowen | $162 → $150 | Maintains | Buy | |||
09/03/2024 | 28.23% | Wells Fargo | $176 → $182 | Maintains | Overweight | |||
08/05/2024 | -2.77% | Barclays | $136 → $138 | Maintains | Equal-Weight | |||
07/31/2024 | 14.14% | TD Cowen | $155 → $162 | Maintains | Buy | |||
07/31/2024 | 9.21% | Raymond James | $150 → $155 | Maintains | Outperform | |||
07/31/2024 | 24% | Wells Fargo | $180 → $176 | Maintains | Overweight | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Peer Perform | |||
07/12/2024 | 2.16% | Scotiabank | $156 → $145 | Maintains | Sector Outperform | |||
07/09/2024 | -4.18% | Barclays | $142 → $136 | Maintains | Equal-Weight | |||
07/02/2024 | 14.14% | JP Morgan | $165 → $162 | Maintains | Overweight | |||
07/01/2024 | 0.05% | Barclays | $147 → $142 | Maintains | Equal-Weight | |||
06/21/2024 | 9.21% | TD Cowen | $164 → $155 | Maintains | Buy | |||
06/20/2024 | 12.73% | Mizuho | $162 → $160 | Maintains | Neutral | |||
06/14/2024 | 6.39% | Piper Sandler | $170 → $151 | Maintains | Overweight | |||
05/30/2024 | 17.66% | Argus Research | $167 → $167 | Reiterates | Buy → Buy | |||
05/30/2024 | 12.73% | Raymond James | $163 → $160 | Maintains | Outperform | |||
05/14/2024 | 19.78% | Piper Sandler | $187 → $170 | Maintains | Overweight | |||
04/30/2024 | 3.57% | Barclays | $155 → $147 | Maintains | Equal-Weight | |||
04/18/2024 | 9.21% | Barclays | $139 → $155 | Maintains | Equal-Weight | |||
04/12/2024 | 14.14% | Mizuho | $167 → $162 | Maintains | Neutral | |||
04/11/2024 | 9.91% | Scotiabank | $148 → $156 | Maintains | Sector Outperform | |||
04/08/2024 | 34.57% | Wells Fargo | $179 → $191 | Maintains | Overweight | |||
04/05/2024 | 31.76% | Piper Sandler | $169 → $187 | Maintains | Overweight | |||
04/01/2024 | 17.66% | JP Morgan | $149 → $167 | Maintains | Overweight | |||
03/22/2024 | 22.6% | Goldman Sachs | $152 → $174 | Maintains | Buy | |||
03/22/2024 | 17.66% | Mizuho | $135 → $167 | Maintains | Neutral | |||
03/20/2024 | 26.12% | Wells Fargo | $163 → $179 | Maintains | Overweight | |||
03/15/2024 | 26.82% | B of A Securities | $150 → $180 | Maintains | Neutral | |||
03/08/2024 | 19.07% | Piper Sandler | $165 → $169 | Maintains | Overweight | |||
02/05/2024 | -2.06% | Barclays | $132 → $139 | Maintains | Equal-Weight | |||
02/01/2024 | 14.85% | Wells Fargo | $151 → $163 | Maintains | Overweight | |||
02/01/2024 | 9.21% | Raymond James | $140 → $155 | Maintains | Outperform | |||
12/19/2023 | -1.36% | Raymond James | $128 → $140 | Maintains | Outperform | |||
12/04/2023 | 5.69% | TD Cowen | $134 → $150 | Maintains | Outperform | |||
10/31/2023 | 2.87% | Wolfe Research | → $146 | Upgrade | Peer Perform → Outperform | |||
10/06/2023 | -18.27% | Mizuho | $131 → $116 | Maintains | Neutral | |||
10/06/2023 | -9.81% | Raymond James | $133 → $128 | Maintains | Outperform | |||
10/05/2023 | -5.59% | Piper Sandler | $138 → $134 | Maintains | Overweight | |||
09/20/2023 | -6.29% | Raymond James | $125 → $133 | Maintains | Outperform | |||
09/18/2023 | 0.75% | B of A Securities | $141 → $143 | Maintains | Neutral | |||
09/18/2023 | -7.7% | Mizuho | $127 → $131 | Maintains | Neutral | |||
09/08/2023 | 1.46% | Wells Fargo | $130 → $144 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Phillips 66 (PSX)?
El último precio objetivo de Phillips 66 (NYSE:PSX) fue comunicado por UBS el noviembre 3, 2025. La firma de analistas fijó un precio objetivo para $160.00 que espera PSX a rise dentro de 12 meses (un posible 12.73% upside). 47 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Phillips 66 (PSX)?
La última calificación de analistas para Phillips 66 (NYSE:PSX) fue proporcionada por UBS, y Phillips 66 mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de Phillips 66 (PSX)?
La última revisión al alza de Phillips 66 se produjo en enero 3, 2025, cuando Wolfe Research elevó su precio objetivo a N/A. Wolfe Research anteriormente tenía a peer perform para Phillips 66.
¿Cuándo fue la última revisión a la baja de Phillips 66 (PSX)?
La última revisión a la baja de Phillips 66 se produjo en noviembre 3, 2025, cuando Freedom Capital Markets cambió su precio objetivo de $127 a $138 para Phillips 66.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Phillips 66 (PSX)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Phillips 66, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Phillips 66 se registró el noviembre 3, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 3, 2026.
¿Es correcta la calificación de los analistas sobre Phillips 66 (PSX)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Phillips 66 (PSX) fue un mantuvo con un precio objetivo de $150.00 a $160.00. El precio actual al que cotiza Phillips 66 (PSX) es de $141.93, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.